1. Home
  2. HUSA vs CTXR Comparison

HUSA vs CTXR Comparison

Compare HUSA & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUSA
  • CTXR
  • Stock Information
  • Founded
  • HUSA N/A
  • CTXR 2007
  • Country
  • HUSA United States
  • CTXR United States
  • Employees
  • HUSA N/A
  • CTXR N/A
  • Industry
  • HUSA Oil & Gas Production
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUSA Energy
  • CTXR Health Care
  • Exchange
  • HUSA Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • HUSA 16.8M
  • CTXR 14.6M
  • IPO Year
  • HUSA N/A
  • CTXR N/A
  • Fundamental
  • Price
  • HUSA $0.75
  • CTXR $1.18
  • Analyst Decision
  • HUSA
  • CTXR Strong Buy
  • Analyst Count
  • HUSA 0
  • CTXR 2
  • Target Price
  • HUSA N/A
  • CTXR $54.50
  • AVG Volume (30 Days)
  • HUSA 401.0K
  • CTXR 598.0K
  • Earning Date
  • HUSA 05-14-2025
  • CTXR 05-13-2025
  • Dividend Yield
  • HUSA N/A
  • CTXR N/A
  • EPS Growth
  • HUSA N/A
  • CTXR N/A
  • EPS
  • HUSA N/A
  • CTXR N/A
  • Revenue
  • HUSA $560,180.00
  • CTXR N/A
  • Revenue This Year
  • HUSA N/A
  • CTXR N/A
  • Revenue Next Year
  • HUSA N/A
  • CTXR N/A
  • P/E Ratio
  • HUSA N/A
  • CTXR N/A
  • Revenue Growth
  • HUSA N/A
  • CTXR N/A
  • 52 Week Low
  • HUSA $0.72
  • CTXR $1.15
  • 52 Week High
  • HUSA $3.20
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • HUSA 28.62
  • CTXR 30.50
  • Support Level
  • HUSA $0.98
  • CTXR $1.21
  • Resistance Level
  • HUSA $0.79
  • CTXR $2.28
  • Average True Range (ATR)
  • HUSA 0.07
  • CTXR 0.20
  • MACD
  • HUSA -0.02
  • CTXR 0.01
  • Stochastic Oscillator
  • HUSA 6.67
  • CTXR 2.65

About HUSA Houston American Energy Corporation

Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Louisiana, and the South American country of Colombia. Geographically, the company currently has operations in two geographical areas, the United States, from where it derives maximum revenue, and Colombia.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: